U.S. Trade Distributors Stock News

In early May 2026, Coupang reported first-quarter 2026 revenue of US$8,504 million, swinging from net income of US$107 million a year earlier to a net loss of US$266 million, while also expanding its equity buyback authorization to US$2.00 billion after repurchasing 29,216,918 shares under its existing program. The results underscored the ongoing impact of a late‑2025 cyber incident, pressuring margins through customer vouchers and underused capacity, even as Coupang recovered nearly 80% of...

TSS, Inc. reported past first-quarter 2026 results with revenue of US$55.35 million and net income of US$2.28 million, down from US$98.96 million and US$2.98 million a year earlier, alongside lower earnings per share. Despite lower headline revenue, management highlighted strong AI-driven systems integration activity, maintained its full-year adjusted EBITDA outlook, and reinforced its AI infrastructure focus with senior hires in strategy and technology. We’ll now examine how this AI-fueled...

If you are wondering whether Monster Beverage is priced attractively or fully reflecting its prospects, the recent share performance gives you plenty to think about. The stock last closed at US$86.29, with returns of 11.9% over 7 days, 14.0% over 30 days, 13.3% year to date, 41.5% over 1 year, 44.9% over 3 years and 87.3% over 5 years. Recent coverage has focused on Monster Beverage's position within the broader beverages sector and how investors are weighing its growth potential against...

Coeur Mining (CDE) is back in focus after reporting record first quarter revenue of US$856.19 million and net income of US$246.76 million, supported by newly acquired New Gold mines and fresh capital return plans. See our latest analysis for Coeur Mining. At a share price of US$18.12, Coeur Mining has seen a 3.25% year to date share price return and a very large 3 year total shareholder return, helped by the New Gold acquisition, strong Q1 results and fresh capital return plans. However, the...

Sea stock reaction and business mix Sea (NYSE:SE) has drawn investor attention after recent share price swings that include a month gain and a decline over the past 3 months, prompting a closer look at how its core businesses and regional exposure line up. See our latest analysis for Sea. Sea’s recent moves tell a mixed story, with a 30 day share price return of 8.95% and a 7 day gain of 4.43% coming after a 90 day share price decline of 18.33% and a 1 year total shareholder return of 39.21%...

In late April 2026, Enphase Energy announced a new safe harbor agreement with a U.S. solar and battery financing company that offers third-party ownership structures, expected to generate about US$52,000,000 in revenue and expand its physical work test backlog for IQ9 Microinverters to roughly US$873,700,000 through 2030. This deal not only deepens Enphase’s footprint in the third-party ownership channel but also points to multi‑year visibility for U.S.-made IQ9 Microinverter demand, with...

Trupanion (TRUP) has moved into focus after reporting first quarter 2026 results, showing net income of US$4.88 million, compared with a net loss of US$1.48 million in the same period a year earlier. See our latest analysis for Trupanion. Recent trading reflects a mixed picture, with a 2.69% 1 day share price return and 6.67% 7 day share price return contrasting with a 31.21% year to date share price decline and a 41.92% 1 year total shareholder return decline. This suggests recent momentum...

For investors wondering whether Fluor stock still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you are getting. Fluor recently closed at US$51.08, with returns of 7.0% over 30 days, 22.5% year to date and 43.4% over 1 year. This puts its longer term 3 year and 5 year returns at 93.0% and 169.8% respectively. Recent coverage has highlighted Fluor's role as a large engineering and...

Wondering if Unity Software at around US$26.73 is offering fair value or if the stock price is out of sync with the business? This article walks through what the numbers are saying so you can judge that for yourself. The stock has returned 1.2% over the past week and 21.4% over the last 30 days, while year to date it shows a 39.6% decline and a 29.4% return over the past year, highlighting that sentiment around risk and potential has shifted more than once. Recent headlines have focused on...

If you are wondering whether BellRing Brands' current share price offers value or just more volatility, it helps to start with what the recent returns are actually telling you. The stock last closed at US$10.46, with returns of a 41.2% decline over 7 days, a 33.2% decline over 30 days, a 59.9% decline year to date and an 83.1% decline over the past year. This clearly changes how many investors think about its potential and its risks. Recent coverage has focused on how the company fits into...

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...

KBR (KBR) is back in focus after a run of sizeable U.S. government wins, including a $449 million Army LOGCAP V extension, a $510 million analytics contract, and fresh Air Force AFCAP V task orders. See our latest analysis for KBR. Despite a series of sizeable government contract wins and reaffirmed guidance, sentiment around KBR has softened, with a 30-day share price return of -12.05% and a 1-year total shareholder return of -38.54% pointing to fading momentum after a tougher few years. If...

monday.com (MNDY) has reintroduced itself as an AI Work Platform, centering its offer on built in AI agents that automate workflows across departments and connect with tools like Anthropic’s Claude and Microsoft 365 Copilot. See our latest analysis for monday.com. The AI Work Platform launch and the upcoming earnings report have arrived after a weak stretch for the stock, with a 90 day share price return of 22.05% decline and a 1 year total shareholder return of 72.88% decline. However,...

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...

Recent Stock Performance Snapshot ZTO Express (Cayman) (ZTO) has drawn investor attention after a recent pullback, with the stock down 2.2% over the past day and 1.1% over the past week, despite positive longer term returns. Over the past month the stock shows a 2.1% gain, while the past 3 months and year to date performance stand at 5.1% and 18.0% respectively. The 1 year total return is 37.7%, although 3 year and 5 year total returns are modestly negative. See our latest analysis for ZTO...

Recent performance snapshot and what it might signal Somnigroup International (SGI) has drawn attention after a period where the stock declined about 10% over the past week and roughly 27% over the past 3 months, despite positive annual revenue and net income growth. See our latest analysis for Somnigroup International. Despite the recent share price pressure, with a 1 day share price return of negative 10.11% and a 90 day share price return of negative 26.63%, Somnigroup International still...

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...

Why Patria Investments (PAX) is on investors’ radar today Patria Investments (PAX) has drawn attention after recent trading left the stock around $12.04, with returns showing mixed signals over the past week, month and past 3 months. See our latest analysis for Patria Investments. The recent 6.8% one day share price decline and 24.4% year to date share price loss contrast with a 9.8% one year total shareholder return. This suggests that recent momentum has faded even as income and past...

In early May 2026, IonQ reported first-quarter 2026 results showing sales of US$64.67 million versus US$7.57 million a year earlier and net income of US$805.36 million, while also advancing its quantum offering through new contracts, quantum networking projects, and the commercial launch of a millimeter-precision InSAR Earth-monitoring product. These developments underscore IonQ’s shift from primarily research-focused roots toward a broader commercial platform spanning quantum computing,...

C.H. Robinson Worldwide (CHRW) shares came under pressure after Amazon said it would open its supply chain services to outside businesses, while a pending Supreme Court case on freight broker liability added another layer of concern. See our latest analysis for C.H. Robinson Worldwide. At a share price of $171.37, C.H. Robinson’s recent 7 day share price return of 5.74% decline and 90 day share price return of 14.57% decline point to fading momentum as investors weigh Amazon’s competitive...

TG Therapeutics (TGTX) drew fresh attention after record-setting Q1 2026 revenue tied to BRIUMVI, a higher full year revenue outlook of about US$925 million, and progress on key Phase 3 clinical milestones. See our latest analysis for TG Therapeutics. The recent six day rally, with a 7 day share price return of 27.37% and a 90 day share price return of 49.08%, suggests momentum has strengthened around Q1 results, raised 2026 guidance and upcoming BRIUMVI Phase 3 readouts. The 1 year total...

GitLab (GTLB) has drawn fresh attention after expanding its integration with Anthropic’s Claude models, incorporating advanced AI agents into its existing DevSecOps governance, compliance, and audit framework for enterprise software development workflows. See our latest analysis for GitLab. At a share price of $25.92, GitLab has seen a 6.71% 1 day and 17.07% 7 day share price return. However, its year to date share price return of 28.36% and 1 year total shareholder return of 47.67% indicate...

In late April 2026, Roblox Corporation reported first-quarter sales of US$1,442 million versus US$1,035 million a year earlier, alongside a wider net loss of US$246 million and higher per-share losses. At the same time, Roblox cut its full-year outlook as new child safety and age-verification measures disrupted user engagement, even as it appointed Sunil Rao to lead expansion in India, one of its fastest-growing markets. Now we’ll examine how lowered guidance tied to friction from new...

Why Medical Properties Trust’s Latest Earnings Matter for Investors Medical Properties Trust (MPT) returned to profitability in the first quarter of 2026, reporting US$252.07 million in revenue and net income of US$32.83 million, after a net loss in the same period last year. See our latest analysis for Medical Properties Trust. The stronger first quarter numbers and return to profitability appear to have supported a short term rebound, with a 7 day share price return of 7.89% and 30 day...